{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:32:33Z","timestamp":1762144353216},"reference-count":28,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T00:00:00Z","timestamp":1233187200000},"content-version":"vor","delay-in-days":3561,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[1999,5]]},"abstract":"<jats:p>\n<jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>We investigated the effects of recombinant human erythropoietin (rh\u2010EPO) in splanchnic artery occlusion (SAO) shock. Sham operated animals were used as controls. Survival rate, mean arterial blood pressure (MAP), serum Tumor Necrosis Factor (TNF\u2010\u03b1), plasma nitrite\/nitrate concentrations, red blood cell (RBC) count, blood haemoglobin (Hb), the responsiveness of aortic rings to phenylephrine (PE, 1\u2003n<jats:sc>M<\/jats:sc>\u201310\u2003\u03bc<jats:sc>M<\/jats:sc>) and the activity of inducible nitric oxide synthase (iNOS) were studied.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>SAO shocked rats had a decreased survival rate (0% at 4\u2003h of reperfusion, while sham shocked rats survived more than 4\u2003h), enhanced serum TNF\u2010\u03b1 concentrations, increased plasma nitrite\/nitrate levels (60\u00b19.5\u2003\u03bc<jats:sc>M<\/jats:sc>; sham shocked rats=2\u00b10.4\u2003\u03bc<jats:sc>M<\/jats:sc>), decreased MAP, unchanged RBC count and blood Hb and enhanced iNOS activity in the aorta. Moreover aortic rings from shocked rats showed a marked hyporeactivity to PE.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Rh\u2010EPO (25, 50 and 100\u2003U\u2003100\u2003g<jats:sup>\u22121<\/jats:sup>, 5\u2003min following the onset of reperfusion) increased survival rate (70% at 4\u2003h of reperfusion with the highest dose), reduced plasma nitrite\/nitrate concentrations (10.3\u00b13.3\u2003\u03bc<jats:sc>M<\/jats:sc>), increased MAP, did not change RBC count and blood Hb, and inhibited iNOS activity in thoracic aortae. Furthermore rh\u2010EPO, either <jats:italic>in vivo<\/jats:italic> or <jats:italic>in vitro<\/jats:italic> (10\u2003U for 1\u2003h in the organ bath), restored to control values the hyporeactivity to PE. Finally rh\u2010EPO inhibited the activity of iNOS in peritoneal macrophages activated with endotoxin.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Our data suggest that rh\u2010EPO protects against SAO shock by inhibiting iNOS activity.<\/jats:p><\/jats:list-item>\n<\/jats:list>\n<\/jats:p><jats:p><jats:italic>British Journal of Pharmacology<\/jats:italic> (1999) <jats:bold>127<\/jats:bold>, 482\u2013488; doi:<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"doi\" xlink:href=\"10.1038\/sj.bjp.0702521\">10.1038\/sj.bjp.0702521<\/jats:ext-link><\/jats:p>","DOI":"10.1038\/sj.bjp.0702521","type":"journal-article","created":{"date-parts":[[2005,1,28]],"date-time":"2005-01-28T20:03:49Z","timestamp":1106942629000},"page":"482-488","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock"],"prefix":"10.1111","volume":"127","author":[{"given":"Francesco","family":"Squadrito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenica","family":"Altavilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Squadrito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe M","family":"Campo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariarita","family":"Arlotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Quartarone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Saitta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achille P","family":"Caputi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,1,29]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)91504-2"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1159\/000187526"},{"key":"e_1_2_7_4_1","first-page":"309","article-title":"Modulatory effect of brain acetylcholine on reflex\u2010induced bradycardia and tachycardia in conscious rats","volume":"215","author":"CAPUTI A.P.","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.295.6605.1017"},{"key":"e_1_2_7_6_1","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.141.7.2407","article-title":"Release of reactive nitrogen intermediates from mouse peritoneal macrophages","volume":"141","author":"DING A.H.","year":"1988","journal-title":"J. Immunol."},{"key":"e_1_2_7_7_1","first-page":"352","article-title":"Blood pressure and erythropoietin","volume":"1","author":"EDMUNDS M.E.","year":"1988","journal-title":"Lancet"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0171-2985(86)80101-2"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105093241907"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1991.31"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1159\/000209613"},{"key":"e_1_2_7_12_1","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1152\/jappl.1993.75.5.2332","article-title":"Nitric oxide inhibition varies with hemoglobin saturation","volume":"75","author":"IWAMOTO J.","year":"1993","journal-title":"J. Appl. Physiol."},{"key":"e_1_2_7_13_1","first-page":"806","article-title":"Isolation and characterization of genomic and cDNA clones of human erythropoietin","volume":"313","author":"JACOBS K.","year":"1985","journal-title":"Lancet"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1992.72.2.449"},{"key":"e_1_2_7_15_1","first-page":"319","article-title":"Pathophysiology of hypertension in dialysis patients treated with erythropoietin (abstract)","volume":"35","author":"MAYER G.","year":"1989","journal-title":"Kidney Int."},{"key":"e_1_2_7_16_1","first-page":"109","volume-title":"Selective pulmonary vasodilation by inhaled nitric oxide is pathophysiology and pharmacology","author":"MONCADA S.","year":"1991"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.43.6.876"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90293-0"},{"key":"e_1_2_7_19_1","doi-asserted-by":"crossref","first-page":"17156","DOI":"10.1016\/S0021-9258(18)45504-4","article-title":"Structural characterization of natural human urinary and recombinant DNA\u2010derived erythropoietin: identification of des\u2010arginine 166 erythropoietin","volume":"262","author":"RECNY M.A.","year":"1987","journal-title":"J. Biol. Chem."},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.88.6.2884"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(95)02099-3"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1994.tb17118.x"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1994.tb17079.x"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1996.tb15672.x"},{"key":"e_1_2_7_25_1","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood.V78.7.1658.1658","article-title":"Pharmacological doses of recombinanthuman erythropoietin in the treatment of myelodysplastic syndromes","volume":"75","author":"STEIN R.S.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1994.tb13078.x"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-199408000-00011"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.1.267"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1992.tb14365.x"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1038%2Fsj.bjp.0702521","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1038%2Fsj.bjp.0702521","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1038\/sj.bjp.0702521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T23:02:03Z","timestamp":1698534123000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1038\/sj.bjp.0702521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["10.1038\/sj.bjp.0702521"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjp.0702521","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,5]]},"assertion":[{"value":"2009-01-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}